SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
March 30, 2004
Date of Report (Date of earliest event reported)
SPECTRUM PHARMACEUTICALS, INC.
| Delaware | 000-28782 | 93-0979187 | ||
| (State or other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification Number) |
| 157 Technology Drive Irvine, California | 92618 | |
| (Address of principal executive offices) | (Zip Code) |
(949) 788-6700
N/A
1
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 12—Disclosure of Results of Operations and Financial Condition. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 7. Financial Statements and Exhibits.
| (c) | Exhibits |
| Exhibits: |
Description of Document |
|
99.1
|
Press Release dated March 30, 2004. |
Item 12—Disclosure of Results of Operations and Financial Condition.
On March 30, 2004 we issued a press release, which sets forth our results of operations for the year ended December 31, 2003. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 30, 2004
| SPECTRUM PHARMACEUTICALS, INC. | ||||||
| By: | /s/ Rajesh C. Shrotriya | |||||
| Name: Rajesh C. Shrotriya, M.D. Title: Chairman, Chief Executive Officer and President |
||||||
2